Showing all 3 results
Cefixime and Linezolid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Potency Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive APIs.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Gram-Negative Anchor: Broad-spectrum bactericidal activity against H. influenzae, E. coli, and Salmonella. Linezolid USP/Ph.Eur. 600 mg The Gram-Positive Powerhouse: Bacteriostatic activity against multi-drug resistant Staphylococci and Streptococci. Excipients Proprietary Matrix Advanced Disintegration System: Engineered utilizing Super-Disintegrants to manage the large 800mg+ active payload, ensuring the tablet shatters rapidly for maximum absorption. Cefixime and Ofloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Extracellular Specialist: Targets the bacterial cell wall; highly effective against Gram-negative enteric pathogens. Ofloxacin USP/Ph.Eur. 200 mg The Intracellular Specialist: Targets DNA replication; excellent tissue penetration into the lungs, prostate, and urinary tract. Excipients Proprietary Matrix Bilayer Technology: Engineered to prevent physical interaction between the two APIs, ensuring maximum stability and a synchronized release profile in the gut. Cefprozil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Monohydrate Tablet, packed in high-barrier Alu-Alu blister strips to prevent hydrolytic degradation.
Active Ingredient Strength Primary Clinical Function Cefprozil USP/Ph.Eur. 250 mg The Pediatric & Mild Infection Anchor: Ideal for Pharyngitis, Tonsillitis, and mild skin infections. Cefprozil USP/Ph.Eur. 500 mg The Respiratory & SSTI Macrodose: Utilized for Acute Sinusitis, secondary infections of Bronchitis, and complicated skin infections. Excipients Proprietary Matrix Hydrolysis-Resistant Formulation: Engineered utilizing high-density granulation to protect the monohydrate API from environmental moisture.
